Nirmidas Biotech, Inc, in collaboration with Stanford’s Departments of Pathology and Medicine, received an award from the National Institute of Health on March 24, 2017.
The grant is for a nanoscale plasmonic-gold platform for specific diagnosis of Zika and differentiation from other flavivirus infections. The underlying technology for this grant was recently published in Nature Medicine. Read more about our Zika Dengue IgG/IgA and IgG Avididty assay kits which are available now. Nanoscale plasmonic-gold platform assay module |  |
For General Inquiries Email: info@nirmidas.com
For Product Support Email: support@nirmidas.com
Nirmidas Biotech, Inc.
319 N. Bernardo Ave
Mountain View, CA, 94043, USA
